A Phase I Evaluation of Extended Field Radiation Therapy With Concomitant Cisplatin Chemotherapy Followed by Paclitaxel and Carboplatin Chemotherapy in Women With Cervical Carcinoma Metastatic to the Para-aortic Lymph Nodes: An NRG Oncology/Gynecologic Oncology Group Study

Oncology Group ◽

Oncology Group Study ◽

Field Radiation ◽

A phase I/II study of extended field radiation therapy with concomitant paclitaxel and cisplatin chemotherapy in patients with cervical carcinoma metastatic to the para-aortic lymph nodes: A gynecologic oncology group study

Gynecologic Oncology ◽

10.1016/j.ygyno.2008.09.035 ◽

2009 ◽

Vol 112 (1) ◽

pp. 78-84 ◽

Cited By ~ 35

Author(s):

Joan L. Walker ◽

Astrid Morrison ◽

Paul DiSilvestro ◽

Vivian E. von Gruenigen

Keyword(s):

Radiation Therapy ◽

Lymph Nodes ◽

Phase I ◽

Cervical Carcinoma ◽

Gynecologic Oncology ◽

Oncology Group ◽

Oncology Group Study ◽

Field Radiation ◽

123 Cervical carcinoma metastatic to PARA-aortic nodes: Extended field radiation therapy with concomitant 5FU/cisplatin chemotherapy. A gynecologic oncology group study

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/s0360-3016(97)85465-x ◽

1996 ◽

Vol 36 (1) ◽

pp. 220 ◽

Cited By ~ 1

Author(s):

Mahesh A. Varia ◽

Brian N. Bundy ◽

Gunther Deppe ◽

Robert Mannell ◽

Hervy Averette ◽

...

Keyword(s):

Radiation Therapy ◽

Cervical Carcinoma ◽

Gynecologic Oncology ◽

Oncology Group ◽

Oncology Group Study ◽

Field Radiation ◽

Cervical carcinoma metastatic to para-aortic nodes: extended field radiation therapy with concomitant 5-fluorouracil and cisplatin chemotherapy: a gynecologic oncology group study

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/s0360-3016(98)00267-3 ◽

1998 ◽

Vol 42 (5) ◽

pp. 1015-1023 ◽

Cited By ~ 168

Author(s):

Mahesh A Varia ◽

Brian N Bundy ◽

Gunter Deppe ◽

Robert Mannel ◽

Hervy E Averette ◽

...

Keyword(s):

Radiation Therapy ◽

Cervical Carcinoma ◽

Gynecologic Oncology ◽

Oncology Group ◽

Oncology Group Study ◽

Field Radiation ◽

Radiation therapy with concomitant paclitaxel and cisplatin chemotherapy in cervical carcinoma limited to the pelvis: A phase I/II study of the Gynecologic Oncology Group

Gynecologic Oncology ◽

10.1016/j.ygyno.2006.06.017 ◽

2006 ◽

Vol 103 (3) ◽

pp. 1038-1042 ◽

Cited By ~ 27

Author(s):

Paul A. DiSilvestro ◽

Joan L. Walker ◽

Astrid Morrison ◽

Peter G. Rose ◽

Howard Homesley ◽

...

Keyword(s):

Radiation Therapy ◽

Phase I ◽

Cervical Carcinoma ◽

Gynecologic Oncology ◽

Oncology Group

A phase I trial of tailored radiation therapy with concomitant cetuximab and cisplatin in the treatment of patients with cervical cancer: A gynecologic oncology group study

Gynecologic Oncology ◽

10.1016/j.ygyno.2012.08.030 ◽

2012 ◽

Vol 127 (3) ◽

pp. 456-461 ◽

Cited By ~ 23

Author(s):

Kathleen N. Moore ◽

Michael W. Sill ◽

David S. Miller ◽

Carolyn McCourt ◽

Koen De Geest ◽

...

Keyword(s):

Cervical Cancer ◽

Radiation Therapy ◽

Phase I ◽

Phase I Trial ◽

Gynecologic Oncology ◽

Oncology Group ◽

Phase I trial of the treatment of high-risk endometrial cancer with concurrent weekly paclitaxel and cisplatin and whole abdominal radiation therapy: A Gynecologic Oncology Group study

Gynecologic Oncology ◽

10.1016/j.ygyno.2008.09.015 ◽

2009 ◽

Vol 112 (1) ◽

pp. 134-141 ◽

Cited By ~ 3

Author(s):

D. Scott McMeekin ◽

Joan L. Walker ◽

Ellen M. Hartenbach ◽

Michael A. Bookman ◽

Wui-Jin Koh

Keyword(s):

Radiation Therapy ◽

Endometrial Cancer ◽

High Risk ◽

Phase I ◽

Phase I Trial ◽

Gynecologic Oncology ◽

Weekly Paclitaxel ◽

Oncology Group ◽

Hydroxyurea, 5-Fluorouracil Infusion, and Cisplatin Adjunct to Radiation Therapy in Cervical Carcinoma: A Phase I–II Trial of the Gynecologic Oncology Group

Gynecologic Oncology ◽

10.1006/gyno.1997.4761 ◽

1997 ◽

Vol 66 (2) ◽

pp. 262-267 ◽

Cited By ~ 31

Author(s):

Frederick B. Stehman ◽

Brian N. Bundy ◽

Paul R. Kucera ◽

Gunther Deppe ◽

Salitha Reddy ◽

...

Keyword(s):

Radiation Therapy ◽

Phase I ◽

Cervical Carcinoma ◽

Gynecologic Oncology ◽

Oncology Group

Posttherapy residual disease associates with long-term survival after chemoradiation for bulky stage 1B cervical carcinoma: a Gynecologic Oncology Group study

American Journal of Obstetrics and Gynecology ◽

10.1016/j.ajog.2010.05.005 ◽

2010 ◽

Vol 203 (4) ◽

pp. 351.e1-351.e8 ◽

Cited By ~ 6

Author(s):

Charles Kunos ◽

Shamshad Ali ◽

Fadi W. Abdul-Karim ◽

Frederick B. Stehman ◽

Steven Waggoner

Keyword(s):

Cervical Carcinoma ◽

Residual Disease ◽

Gynecologic Oncology ◽

Oncology Group ◽

Term Survival ◽

Oncology Group Study ◽

Long Term Survival

A phase II trial of didemnin B (NSC No. 325319) in advanced and recurrent cervical carcinoma: A Gynecologic Oncology Group study

Gynecologic Oncology ◽

10.1016/0090-8258(92)90055-n ◽

1992 ◽

Vol 44 (3) ◽

pp. 268-270 ◽

Cited By ~ 11

Author(s):

Allan J. Jacobs ◽

John A. Blessing ◽

Alan Munoz

Keyword(s):

Cervical Carcinoma ◽

Phase Ii ◽

Phase Ii Trial ◽

Gynecologic Oncology ◽

Didemnin B ◽

Oncology Group ◽

A Phase I Trial of Prolonged Oral Etoposide and Liposomal Doxorubicin in Ovarian, Peritoneal, and Tubal Carcinoma: A Gynecologic Oncology Group Study

Gynecologic Oncology ◽

10.1006/gyno.2002.6584 ◽

2002 ◽

Vol 85 (1) ◽

pp. 136-139 ◽

Cited By ~ 7

Author(s):

Peter G. Rose ◽

Michael Rodriguez ◽

Joan Walker ◽

Benjamin Greer ◽

Nancy Fusco ◽

...

Keyword(s):

Phase I ◽

Phase I Trial ◽

Liposomal Doxorubicin ◽

Gynecologic Oncology ◽

Oral Etoposide ◽

Oncology Group ◽